Adam Spiker is executive director of the Southern California Coalition, which is an organization dedicated to helping organizations, advocacy groups, and businesses coalition build and understand the cannabis industry.
Spiker sits down with Alyssa Julya Smith in Los Angeles to talk about how to implement responsible policies in Los Angeles, the state of California, and at the federal level. He explains that the city of Los Angeles is the biggest cannabis market in the world, but has been slow to roll out licenses across the city.
Spiker also discusses the need for more resources to go through all the applications, both for distributors and cultivators who are trying to legally expand their business. Spiker also emphasizes that he believes the state will do everything in their power to protect business from the threat of federal regulations and roadblocks.
The Biden administration says it will impose inflation penalties on dozens of drug makers to lower costs for those on Medicare.
Two of the top low-cost online retailers are going head to head in a new legal battle. Cheddar News' Michelle Castillo breaks the lawsuit down.
The number of Americans filing for jobless benefits fell last week as the labor market continues to thrive despite high interest rates and elevated costs.
The earliest version of Disney's Mickey Mouse will become public domain on Jan. 1, 2024.
The toy magic oven called the Cookeez Makery is one of the hottest toys for kids this holiday season.
In the UK, IKEA is looking to give away some meatballs, and not just regular-size meatballs.
Dwayne 'The Rock' Johnson is set to star in a movie playing MMA and UFC legend, Mark Care, while Kevin Hart will headline a boxing project over on Peacock.
Coca-Cola is recalling drinks sold in three southern states due to possible "foreign materials" inside cans.
Stocks jumped after the Dow Jones closed at a record high while fresh retail sales data showed positive consumer spending ahead of the holidays.
The Food and Drug Administration is asking Congress for new powers, including the ability to mandate drug recalls and require eyedrop makers to undergo inspections before shipping products to the U.S.
